Transition metal-mediated [3 + 2 + 2] allyl/alkyne cycloaddition reactions. A new reactivity pattern for the synthesis of seven-membered carbocycles

DOI: 10.1021/ja00136a028

Source and publish data:

Journal of the American Chemical Society p. 8275 - 8276 (1995)

Update date:2022-09-26

Topics:

Authors:

Schwiebert, Kathryn E.

Stryker, Jeffrey M.

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1021/ja00136a028

Full text of DOI:10.1021/ja00136a028

Products guided by the article

Product name:C₅(CH₃)5IrC₇H₆(CH₃)2(C₆H₅)⁽¹⁺⁾*CF₃SO₃^(1-)=[C₅(CH₃)5IrC₇H₆(CH₃)2(C₆H₅)]CF₃SO₃

Cas No:168065-51-8

R&D Labs maybe for 168065-51-8

Sichuan Sangao Biochemical Co., Ltd

Contact:+86-28-84874233

Address:19F, Bldg.2, Shudu Center, Tianfu 2nd St., Hi-tech zone, Chengdu 610041, Sichuan Province, China.
Wuxi Zuping Food Science And Technology Co.,LTD.

Contact:+86-510-87210822

Address:Guanlin town
Xi'an HO-SHINE Bio-Technology Co., Ltd

Contact:+86 (29) 8248-5435/18292020086

Address:No.6 Shiyuan Road Xian City Shaanxi Province, 710048 China
Zhejiang Tianyu Pharmaceutical Co., Ltd.

Contact:+86-576-84177669, 89189665,89189688,84168770

Address:Jiangkou Development Zone, Huangyan, Taizhou City, Zhejiang
Rugao Jinling Chemical Co., Ltd.(expird)

Contact:0086-513-68005586

Address:Lianluo new village huangshi town Rugao city Jiangsu Province.

Relevant to this article

Doi:10.1002/ardp.19122500120
(1912)
Doi:10.1039/jr9380000188
(1938)
Balanced AT₁/AT₂ receptor antagonists. 4. XR510 and related 5-(3- amidopropanoyl)imidazoles possessing equal affinity for the AT₁ and AT₂ receptors

Doi:10.1021/jm00015a016
(1995)
Asymmetric functionalization of chromium carbene-derived optically active 4,4-disubstituted butenolides

Doi:10.1021/jo00117a034
(1995)
Mechanistic studies of aliphatic ligand hydroxylation of a copper complex by dioxygen: A model reaction for copper monooxygenases

Doi:10.1021/ja972809q
(1998)
Potent and selective ET-A antagonists. 1. Syntheses and structure-activity relationships of N-(6-(2-(aryloxy)ethoxy)-4-pyrimidinyl)sulfonamide derivatives

Doi:10.1021/jm0102304
(2001)

Article Doi